Ottimo Pharma
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
See more in Biomedtracker
Latest on Ottimo Pharma
In Vivo
• By Eleanor Malone
Looking ahead to 2025, industry leaders shared their insights into the key trends and topics they expect to see. Click on topic headings to read executive predictions. The insights in this article hav
Scrip
• By Eleanor Malone
“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office